logo

Shariah compliance overview

Not Halal

Akari Therapeutics, Plc (AKTX) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Akari Therapeutics, Plc

Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing.

Akari Therapeutics, Plc (AKTX) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing debt, Interest-bearing securities and assets.

Business Activity
100.00%Limit 5%Fail
Interest-bearing debt
162.59%Limit 30%Fail
Interest-bearing securities and assets
1121.96%Limit 30%Fail
Dividend purification
100.00%Share of dividends to give to charityPurification calculator

Last updated: Oct 23, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Akari Therapeutics, Plc (AKTX). Current Akinda screening label: Not Halal.